SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Aug 8, 2025

2. SEC Identification Number

34218

3. BIR Tax Identification No.

000-153-610-000

4. Exact name of issuer as specified in its charter

AYALA CORPORATION

5. Province, country or other jurisdiction of incorporation

PHILIPPINES

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

37F to 39F, Ayala Triangle Gardens Tower 2, Paseo de Roxas cor Makati Avenue, Makati City Postal Code 1226

8. Issuer's telephone number, including area code

(02) 7908-3000

9. Former name or former address, if changed since last report

NA

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares	624,036,976
Preferred A Shares (Reissued)	5,244,515
Preferred B Series 3 Shares	7,500,000
Preferred B Series 4 Shares	10,000,000
Voting Preferred Shares	200,000,000

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Ayala CorporationAC

PSE Disclosure Form 4-30 - Material Information/Transactions References: SRC Rule 17 (SEC Form 17-C) and
Sections 4.1 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Execution by Ayala Healthcare Holdings, Inc. (“AC Health”), a wholly owned subsidiary of Ayala Corporation (the “Corporation”), and IMP2 Rise Pte. Ltd., a special purpose vehicle of ABC Impact Fund II LP (“ABC Impact”) of an Investment Agreement for ABC Impact’s investment in AC Health
Background/Description of the Disclosure
On August 8, 2025, the Executive Committee of the Corporation's Board of Directors and the Board of Directors of AC Health approved the investment by ABC Impact through IMP2 Rise Pte. Ltd.'s subscription to common shares and redeemable preferred shares of AC Health equivalent to a ~16% economic stake (the “Transaction”). ABC Impact is a Singapore-based impact investor dedicated to Asia and backed by Temasek Trust and Temasek. On the same date, AC Health and ABC Impact executed the Investment Agreement relating to the Transaction. The completion of the Transaction is subject to satisfaction of conditions precedent. The Transaction is aligned with AC Health’s vision of transforming healthcare for every Filipino, by building a seamless and integrated healthcare ecosystem. Furthermore, the investment supports AC Health’s expansion across its core pillars of hospitals, multi-specialty clinics, and retail pharmacies – through a combination of organic initiatives and targeted acquisitions. By 2027, AC Health aims to expand its network to at least 10 hospitals, 300 clinics, and 1,150 pharmacies.
Other Relevant Information
See attached Press Release